Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis (original) (raw)

• Alt JR, Cleveland JL, Hannink M, Diehl JA . (2000). Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 14: 3102–3114.
  Article CAS PubMed PubMed Central Google Scholar
• Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M et al. (2003). Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114: 359–370.
  Article CAS PubMed Google Scholar
• Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG et al. (2006). Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 25: 6291–6303.
  Article CAS PubMed Google Scholar
• Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM . (1994). Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13: 2124–2130.
  Article CAS PubMed PubMed Central Google Scholar
• Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI et al. (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127–2133.
  CAS PubMed Google Scholar
• Butt AJ, McNeil CM, Musgrove EA, Sutherland RL . (2005). Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr Relat Cancer 12 (Suppl 1): S47–S59.
  Article CAS PubMed Google Scholar
• Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19: 968–988.
  Article CAS PubMed Google Scholar
• Cheng M, Sexl V, Sherr CJ, Roussel MF . (1998). Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 95: 1091–1096.
  Article CAS PubMed Google Scholar
• Diehl JA, Cheng M, Roussel MF, Sherr CJ . (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499–3511.
  Article CAS PubMed PubMed Central Google Scholar
• Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E et al. (2004). Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 3: 1427–1438.
  CAS PubMed Google Scholar
• Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA . (2006). Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 25: 998–1007.
  Article CAS PubMed PubMed Central Google Scholar
• Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC . (1999). Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98: 859–869.
  Article CAS PubMed Google Scholar
• Hennighausen L, McKnight R, Burdon T, Baik M, Wall RJ, Smith GH . (1994). Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development. Cell Growth Differ 5: 607–613.
  CAS PubMed Google Scholar
• Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M et al. (2004). Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430: 797–802.
  Article CAS PubMed Google Scholar
• Ip MM, Asch BB . (2000). Methods in Mammary Gland Biology and Breast Cancer Research. Kluwer Academic/Plenum Publishers: New York.
  Book Google Scholar
• Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW . (2006). Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9: 13–22.
  Article CAS PubMed Google Scholar
• Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ et al. (2006). Phosphorylation-dependent ubiquitination of Cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 24: 355–366.
  Article CAS PubMed PubMed Central Google Scholar
• Lu F, Gladden AB, Diehl JA . (2003). An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 63: 7056–7061.
  CAS PubMed Google Scholar
• McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD . (2006). p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol 4: e51.
  Article PubMed PubMed Central Google Scholar
• Rowse GJ, Ritland SR, Gendler SJ . (1998). Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. Cancer Res 58: 2675–2679.
  CAS PubMed Google Scholar
• Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H et al. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621–630.
  Article CAS PubMed Google Scholar
• Utsumi T, Yoshimura N, Maruta M, Takeuchi S, Ando J, Mizoguchi Y et al. (2000). Correlation of cyclin D1 MRNA levels with clinico-pathological parameters and clinical outcome in human breast carcinomas. Int J Cancer 89: 39–43.
  Article CAS PubMed Google Scholar
• Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, Machida Y et al. (2003). A p53-dependent checkpoint pathway prevents rereplication. Mol Cell 11: 997–1008.
  Article CAS PubMed Google Scholar
• Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV . (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671.
  Article CAS PubMed Google Scholar
• Yu Q, Geng Y, Sicinski P . (2001). Specific protection against breast cancers by cyclin D1 ablation. Nature 411: 1017–1021.
  Article CAS PubMed Google Scholar
• Yu Q, Sicinska E, Geng Y, Ahnstrom M, Zagozdzon A, Kong Y et al. (2006). Requirement for CDK4 kinase function in breast cancer. Cancer Cell 9: 23–32.
  Article CAS PubMed Google Scholar